Baxter International Inc vs Enovix Corporation — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.36B), while Enovix Corporation trades at $4.9 (market cap $1.01B). The key difference: Baxter International Inc is far larger — about 14.2× Enovix Corporation's market cap, and Baxter International Inc pays a 0.14% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals.
| BAX | ENVX | |
|---|---|---|
Market Cap | $14.36B | $1.01B |
Sector | Health | Technology |
52-Week High | $28.35 | $13.19 |
52-Week Low | $15.80 | $3.68 |
Enterprise Value | $21.88B | $1.03B |
Dividend Yield | 0.14% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVX trades at $4.70, up 10.33% today, with a bullish technical signal despite negative profitability. Recent earnings beats and a $12.38 consensus price target suggest upside potential. The company is ramping production of advanced silicon-anode batteries, with key developments including a new COO appointment and upcoming Q2 2026 results on August 12, 2026.
Outlook remains speculative with high revenue growth potential but persistent losses; risks include cash burn and competitive pressures. Analyst sentiment is positive (75% buy ratings), but investors should weigh the long-term growth story against near-term financial challenges.
Trailing returns across standard periods
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →